PAT-PM-2

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePAT-PM-2
Drug Alias Namemonoclonal antibody PM-2 (Patrys/Takeda)monoclonal antibody PM-2 (Oncomab/Acceptys)PAT-PM-2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunoglobulin M agonists
TargetsImmunoglobulin M
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New ZealandGermany +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOncomab Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncomab GmbhAcceptys IncPatrys Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A